Treatment of equine laminitis
AssigneeMeri Charmyne Russell
InventorMeri Charmyne Russell
Life of this patent
Estimating the term…
Abstract
Compositions and methods of the topical treatment of equine laminitis are disclosed. In particular, combinations of a fast acting nitric oxide (NO) donor, a sustained acting NO donor and an NSAID mixed in a lipid-based carrier are described. The application of such combinations to the affected areas, e.g., the hoofs and surrounding tissues, of an equine afflicted with laminitis provides relief from the debilitating effects of this painful, often life-threatening condition.
Claims13
A method of ameliorating the adverse effects of equine laminitis comprising topically administering to the affected areas of an equine an effective amount of a fast acting nitric oxide (NO) donor and a slow acting NO donor dispersed in a lipid-based carrier and continuing to administer said combination until the equine exhibits signs of recovery, said recovery comprises regaining the ability to stand, improved posture, normal gait, improved appetite, or improved or stabilized organ function.
A method of ameliorating the adverse effects of equine laminitis which comprises topically administering at least once daily to the affected areas of an equine a combination comprising at least one fast acting NO donor at least one slow acting donor, L-Arg, and at least one NSAID in a lipid-based carrier;
- in an amount sufficient to promote signs of recovery, said recovery comprises regaining the ability to stand, improved posture, normal gait, improved appetite, or improved or stabilized organ function.
Dependencies are inferred from the claim text.